IL42701A - Antibiotic "ta" - Google Patents
Antibiotic "ta"Info
- Publication number
- IL42701A IL42701A IL42701A IL4270173A IL42701A IL 42701 A IL42701 A IL 42701A IL 42701 A IL42701 A IL 42701A IL 4270173 A IL4270173 A IL 4270173A IL 42701 A IL42701 A IL 42701A
- Authority
- IL
- Israel
- Prior art keywords
- antibiotic
- chloroform
- atcc
- methanol
- culture medium
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title claims description 69
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- VQWNGCSUNKJFLW-ACPVBGRSSA-N Antibiotic TA Chemical compound CCCC1OC(=O)C(C)CC(C)CCCCC(=O)CCCC(CC)\C=C\C=C(COC)\CCC(O)C(O)CC(O)CNC1=O VQWNGCSUNKJFLW-ACPVBGRSSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 241000863422 Myxococcus xanthus Species 0.000 claims description 9
- 108010079058 casein hydrolysate Proteins 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 238000001228 spectrum Methods 0.000 claims description 5
- 230000012010 growth Effects 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000009630 liquid culture Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 238000005273 aeration Methods 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims 1
- 235000019341 magnesium sulphate Nutrition 0.000 claims 1
- 239000012265 solid product Substances 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 8
- 235000012239 silicon dioxide Nutrition 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000006916 nutrient agar Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241001647006 Myxococcus virescens Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241001522878 Escherichia coli B Species 0.000 description 2
- 241000251748 Myxinidae Species 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 235000002725 Olea europaea Nutrition 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- JIDVGUQUQSOHOL-UHFFFAOYSA-N myxin Chemical compound C1=CC=C2[N+]([O-])=C3C(OC)=CC=CC3=[N+]([O-])C2=C1O JIDVGUQUQSOHOL-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- 241000207965 Acanthaceae Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241000863434 Myxococcales Species 0.000 description 1
- 241000863420 Myxococcus Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241001532577 Sorangium Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- YSVZGWAJIHWNQK-UHFFFAOYSA-N [3-(hydroxymethyl)-2-bicyclo[2.2.1]heptanyl]methanol Chemical compound C1CC2C(CO)C(CO)C1C2 YSVZGWAJIHWNQK-UHFFFAOYSA-N 0.000 description 1
- MHLMRBVCMNDOCW-UHFFFAOYSA-N acetic acid;butan-1-ol;hydrate Chemical compound O.CC(O)=O.CCCCO MHLMRBVCMNDOCW-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000023149 myxospore formation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000024001 sorocarp development Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 description 1
- 229940126572 wide-spectrum antibiotic Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
- C07G11/00—Antibiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL42701A IL42701A (en) | 1973-07-10 | 1973-07-10 | Antibiotic "ta" |
| GB2893274A GB1477518A (en) | 1973-07-10 | 1974-06-28 | Antibiotic and process for the production thereof |
| US05/485,935 US3973005A (en) | 1973-07-10 | 1974-07-05 | Antibiotic TA |
| CA204,155A CA1039213A (en) | 1973-07-10 | 1974-07-05 | Antibiotic ta from myxococcus xanthus |
| CH954674A CH615221A5 (da) | 1973-07-10 | 1974-07-10 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL42701A IL42701A (en) | 1973-07-10 | 1973-07-10 | Antibiotic "ta" |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL42701A0 IL42701A0 (en) | 1973-10-25 |
| IL42701A true IL42701A (en) | 1977-08-31 |
Family
ID=11047218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL42701A IL42701A (en) | 1973-07-10 | 1973-07-10 | Antibiotic "ta" |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3973005A (da) |
| CA (1) | CA1039213A (da) |
| CH (1) | CH615221A5 (da) |
| GB (1) | GB1477518A (da) |
| IL (1) | IL42701A (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4104369A (en) * | 1976-08-31 | 1978-08-01 | State Of Michigan | Lymphosarcin and method of producing lymphosarcin |
| EP0262085A1 (de) * | 1986-08-15 | 1988-03-30 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Antibiotika aus Myxococcus |
| US5532231A (en) * | 1994-11-01 | 1996-07-02 | Ramot University Authority For Applied Research And Industrial Development Ltd. | Antibacterial agent |
| US20040235107A1 (en) * | 1999-01-29 | 2004-11-25 | Ramot At Tel Aviv University Ltd. | Biosynthesis of TA antibiotic |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1800363A1 (de) * | 1967-10-04 | 1969-07-03 | Shionogi & Co | Tsushimycin und seine Herstellung |
-
1973
- 1973-07-10 IL IL42701A patent/IL42701A/en unknown
-
1974
- 1974-06-28 GB GB2893274A patent/GB1477518A/en not_active Expired
- 1974-07-05 US US05/485,935 patent/US3973005A/en not_active Expired - Lifetime
- 1974-07-05 CA CA204,155A patent/CA1039213A/en not_active Expired
- 1974-07-10 CH CH954674A patent/CH615221A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL42701A0 (en) | 1973-10-25 |
| US3973005A (en) | 1976-08-03 |
| GB1477518A (en) | 1977-06-22 |
| CA1039213A (en) | 1978-09-26 |
| CH615221A5 (da) | 1980-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2552638B2 (de) | Thienamycin, Verfahren zu seiner Herstellung und Thienamycin enthaltende Arzneimittel | |
| US3338786A (en) | Antibiotic av290 and production thereof | |
| JP3131574B2 (ja) | 新規抗腫瘍物質、該物質を製造するための微生物及び方法、並びに該物質を有効成分とする細胞周期阻害剤及び抗腫瘍剤 | |
| Ishibashi | Studies on antibiotics from Helminthosporium sp. fungi. VII Siccanin, a new antifungal antibiotic produced by Helminthosporium siccans | |
| CA1113873A (en) | Antibiotic g-6302 | |
| DE2513855A1 (de) | Neue antibiotika, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| IL42701A (en) | Antibiotic "ta" | |
| JPS5920354B2 (ja) | 抗真菌および抗原生動物性抗生物質ならびにその製造法 | |
| US3928572A (en) | Myriocin and process of preparation | |
| FI100112B (fi) | Menetelmä bakteerien vastaisen tiomarinolin valmistamiseksi | |
| JPS61216692A (ja) | Ｃｌ‐１５７７‐ｂ↓４化合物およびその製法 | |
| US3592925A (en) | Antibiotics ah272alpha2 and ah272beta2 and process for producing same | |
| DE3586469T2 (de) | Crisamicin-antibiotikum, seine herstellung und verwendung und ein mikroorganismus, der dieses produzieren kann. | |
| US3898327A (en) | Antibiotic azdimycin | |
| CH626628A5 (en) | Process for the preparation of an antibiotic | |
| US3377243A (en) | Antibiotic ra-6950beta and method of production using streptomyces ochrosporus | |
| JPS5948992B2 (ja) | 抗生物質ｃ−１４４８２ａ↓１ | |
| US3061516A (en) | Telomycin and its production | |
| US5192742A (en) | Compounds and compositions for the treatment of bacterial infections in animals | |
| US3873693A (en) | Ionomycin | |
| CA1046965A (en) | Naphthyridinomycin antibiotics from streptomyces | |
| US3377244A (en) | Antibiotic ao-341 and production thereof | |
| US3219530A (en) | Porfiromycin antibiotic and production thereof | |
| KR880001638B1 (ko) | 항종양성 항생물질 루조펩틴 e₂ 및 그 제조방법 | |
| JP4500937B2 (ja) | セペドニウム・クロリヌムの生産する新規エピジチオジケトピペラジン系抗細菌抗生物質ｍｍｒｃ０３−０００１ |